Literature DB >> 33769906

AIRMESS - Academy of International Regenerative Medicine & Surgery Societies: recommendations in the use of platelet-rich plasma (PRP), autologous stem cell-based therapy (ASC-BT) in androgenetic alopecia and wound healing.

Pietro Gentile1,2, Rubina Alves3,4, John P Cole5,6, Katarina Andjelkov7,8, Thierry Van Helmelryck9, Jonathan Fernandez10, Angelo Trivisonno11, Lemierre Guillaume12, Alexis Verpaele13, Patrick Tonnard14, Jeremy Magalon15, Guy Magalon16,17, Sophie Menkes18,19.   

Abstract

INTRODUCTION: Many investigations showed that platelet-rich plasma (PRP), human follicles stem cells (HFSCs), and adipose-derived stem cells (ASCs), considered autologous stem cell-based therapy (ASC-BT), are effective for hair regrowth (HR) in patients affected by androgenetic alopecia and for wound healing (WH). The aim of this article is to analyze the in vitro and in vivo impact of different PRP, HFSCs, and ASCs preparation methods on HR and in WH. AREAS COVERED: The analyzed data intended to clarify the molecular mechanism in which PRP, HFSCs, and ASCs are involved, the clinical use and related indications, fully respecting the European rules. Comparative studies between different systems of PRP, HFSCs, and ASCs preparation revealed differences in terms of HR and WH. EXPERT OPINION: Despite a lack of standardized protocols, there is convincing evidence with objective measurement modalities that display positive outcomes of ASC-BT in HR and WH.

Entities:  

Keywords:  ASCS; HFSC; PRP in androgenetic alopecia; PRP in hair loss; Plastic surgery; adipose-derived stem cells; hair regrowth; human follicle stem cells; platelet-rich plasma; regenerative plastic surgery; wound healing

Mesh:

Year:  2021        PMID: 33769906     DOI: 10.1080/14712598.2021.1908995

Source DB:  PubMed          Journal:  Expert Opin Biol Ther        ISSN: 1471-2598            Impact factor:   4.388


  5 in total

1.  Knockout of integrin β1 in induced pluripotent stem cells accelerates skin-wound healing by promoting cell migration in extracellular matrix.

Authors:  Yansong Ren; Jinbo Liu; Huijun Xu; Shun Wang; Shirui Li; Meng Xiang; Sifeng Chen
Journal:  Stem Cell Res Ther       Date:  2022-07-30       Impact factor: 8.079

2.  Safety and efficacy of ALRV5XR in men with androgenetic alopecia: A randomised, double-blinded, placebo-controlled clinical trial.

Authors:  Peter R Feldman; Klaus M Fiebig; Charles Piwko; Boris M Mints; Dennis Brown; Deborah J Cahan; Jaime Guevara-Aguirre
Journal:  EClinicalMedicine       Date:  2021-09-11

Review 3.  MSCs and their exosomes: a rapidly evolving approach in the context of cutaneous wounds therapy.

Authors:  Faroogh Marofi; Kozlitina Iuliia Alexandrovna; Ria Margiana; Mahta Bahramali; Wanich Suksatan; Walid Kamal Abdelbasset; Supat Chupradit; Maryam Nasimi; Marwah Suliman Maashi
Journal:  Stem Cell Res Ther       Date:  2021-12-04       Impact factor: 6.832

4.  Human adipose-derived mesenchymal stem cells-derived exosomes encapsulated in pluronic F127 hydrogel promote wound healing and regeneration.

Authors:  Yang Zhou; Xing-Liao Zhang; Shou-Tao Lu; Ning-Yan Zhang; Hai-Jun Zhang; Jing Zhang; Jun Zhang
Journal:  Stem Cell Res Ther       Date:  2022-08-08       Impact factor: 8.079

5.  Sex differences in clinical trials of ALRV5XR treatment of androgenetic alopecia and telogen effluvium.

Authors:  Peter R Feldman; Oriel J Feldman; Jaime Guevara-Aguirre; Klaus M Fiebig
Journal:  Front Med (Lausanne)       Date:  2022-08-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.